| Literature DB >> 29018266 |
Philip C Hogan1, Chi-Li Chen1, Kristen M Mulvihill1, Jonathan F Lawrence1, Eric Moorhead1, Jens Rickmeier2, Andrew G Myers2.
Abstract
Key building blocks for the production of fully synthetic macrolides have been scaled-up in first time pilot plant and kilo-lab campaigns. These building blocks have supported the discovery of new macrolide antibiotics as well as ongoing preclinical studies.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29018266 DOI: 10.1038/ja.2017.116
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649